Home > PE Ratio > SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of SUVEN PHARMACEUTICALS is 44.27.

Share Price ₹644.9Apr 25,2024
Market Cap ₹16,417.9 Cr
Earnings-TTM₹370.9 CrTTM-Consolidated Results
Price/Earnings44.27xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for SUVEN PHARMACEUTICALS
Please provide your vote to see the results
SUVEN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals

Definition & Calculation of PE (Price/Earnings) ratio of SUVEN PHARMACEUTICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of SUVEN PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹16,417.9 Cr] as on Apr 25,2024

(/) Earnings [ ₹370.9 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 44.27x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for SUVEN PHARMACEUTICALS , the investors are currently willing to pay 44.27 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SUVEN PHARMACEUTICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of SUVEN PHARMACEUTICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of SUVEN PHARMACEUTICALS


PE Ratio Performance Analysis for SUVEN PHARMACEUTICALS

- SUVEN PHARMACEUTICALS 's latest p/e ratio is 44.27x.

- SUVEN PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 20.55x.

- SUVEN PHARMACEUTICALS 's operated at median p/e ratio of 29.26x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, SUVEN PHARMACEUTICALS 's p/e ratio peaked in Mar2021 at 34.8x.

- SUVEN PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2019 of 0x.


How does SUVEN PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
SUVEN PHARMACEUTICALS 370.8844.2716,417.9
SUN PHARMACEUTICAL INDUSTRIES LTD8,998.6340.54364,831.0
CIPLA LTD3,744.0330.31113,471.0
DR REDDYS LABORATORIES LTD5,209.4019.91103,713.0
ZYDUS LIFESCIENCES LTD2,954.2032.3995,687.8
DIVIS LABORATORIES LTD1,382.9773.73101,960.0
MANKIND PHARMA LTD1,743.3055.1296,093.1
TORRENT PHARMACEUTICALS LTD1,494.0060.9991,124.7
LUPIN LTD1,809.7440.1672,687.6
AUROBINDO PHARMA LTD2,777.8923.2864,661.3
ABBOTT INDIA LTD1,145.5847.6054,533.1

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SUVEN PHARMACEUTICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 19.91x
Max industry PE 73.73x
Median industry PE 40.54x
Average industry PE 42.57x



You may also like the below Video Courses